Canandaigua National Corp’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Buy
+86,888
New +$10M 0.94% 22
2022
Q4
$12.6M Buy
113,164
+15
+0% +$1.53K 2.13% 7
2022
Q3
$9.74M Buy
113,149
+9,863
+10% +$880K 1.73% 10
2022
Q2
$9.42M Sell
103,286
-3,326
-3% -$295K 1.67% 10
2022
Q1
$8.75M Buy
106,612
+20,218
+23% +$1.59M 1.33% 14
2021
Q4
$6.62M Buy
86,394
+6,445
+8% +$513K 0.98% 24
2021
Q3
$6M Buy
79,949
+119
+0.1% +$9.05K 0.98% 26
2021
Q2
$6.21M Sell
79,830
-4,145
-5% -$308K 1.01% 23
2021
Q1
$6.18M Sell
83,975
-2,135
-2% -$157K 1.04% 22
2020
Q4
$6.72M Sell
86,110
-8,657
-9% -$662K 1.18% 18
2020
Q3
$7.5M Buy
94,767
+1,518
+2% +$119K 1.33% 15
2020
Q2
$6.88M Buy
+93,249
New +$7.02M 1.26% 17

Other funds holding MRK

Canandaigua National Corp's MRK Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Merck (MRK) in Q1 2026: 86,888 shares worth $10.5M. The stake represents 0.94% of the portfolio and ranks #22 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in MRK as recently as Q4 2022.

Canandaigua National Corp first reported a position in MRK in Q2 2020 and has held it in 12 quarters since. The position peaked at $12.6M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Canandaigua National Corp held 86,888 shares of Merck worth $10.5M as of Q1 2026.
  • Merck was a new Canandaigua National Corp position in Q1 2026.
  • Merck made up 0.94% of Canandaigua National Corp's portfolio in Q1 2026, its #22 holding.
  • Canandaigua National Corp first reported a position in Merck in Q2 2020 and has held it in 12 quarters since.
  • Canandaigua National Corp's Merck position peaked at $12.6M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.